– Elligo Health Research, a healthcare-enabling research organization powered by the novel IntElligo technology, announced a $135m Series E financing round.
– Morgan Stanley Expansion Capital and Ally Bridge Group participated in the financing round.
– The round was also participated by Norwest Venture Partners and all major existing investors, including Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, and Syneos Health.
– This financing allows Elligo to invest further in its technology platform and leverage data in new ways to address current challenges in the clinical trial industry.

– GumGum is a global contextual advertising technology company based in Santa Monica, California.
– The company raised $75m in funding.
– Goldman Sachs Growth joined existing investors Upfront Ventures, NewView Capital, and Morgan Stanley Expansion Capital.
– The new investment will be used to accelerate the adoption of its contextual intelligence advertising product suite and expand investments in key international markets.